Medical Device News Magazine

A&G Real Estate Partners Accepting Offers on 11 Medical Office Buildings in Northern New Jersey, Florida and New York

Investors can acquire individual or multiple assets or enter into a joint venture with the existing owner; offers must be submitted by October 18

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

A&G Real Estate Partners is now accepting offers on nine medical office properties in northern New Jersey and one each in Mount Kisco, New York, and Miramar, Florida.

Prospective buyers can purchase individual assets or acquire all 11 properties. Alternatively, the current owner—a medical doctor who built the portfolio over the last 10 years—would consider a joint venture.

All offers must be submitted by October 18.

“The owner has signed several new tenants recently and enjoys good working relationships with the rest,” noted A&G Co-President Emilio Amendola, who heads the New York-based firm’s real estate sales division.

“The portfolio, which has been historically under-managed because of cash-flow disruptions, is now primarily stabilized while still offering significant upside on several of the buildings,” Amendola said. “With reinvestment capital and professional approaches to leasing and management, buyers of any of these properties could achieve a healthy return on their investment.”

The New Jersey properties are in Oradell, Carlstadt, Hackensack, Jersey City, Glen Rock, Roseland and New Brunswick, along with two buildings in Fair Lawn.

The average building size, including assets in Mount Kisco, NY, and Miramar, FL. is about 27,000 square feet.

“Current tenants include labs, dental practices, business offices and regional surgery centers. New leases have just been signed that will increase revenue by more than $1 million,” Amendola said.

The 310,290-square-foot portfolio is 82 percent leased, with 12-month projected net operating income of approximately $5.5 million. Net Incomes on an individual property basis range from $150,000 to over $1,250,000 per year.

All 11 properties are in dense, well-populated markets with easy access to nearby hospitals and specialty clinics. For example, the 12,660-square-foot medical office building at 215 Easton Ave. in New Brunswick is across the street from Saint Peter’s University Hospital and serves as the cancer treatment center for this regional medical center.

The 72,715-square-foot medical office at 103-105 South Bedford Rd. in Mount Kisco is a quarter of a mile from Northwell Health’s Northern Westchester Hospital—a highly developed area with a high barrier to entry for new competitors.

To submit offers and for further information, visit https://www.agrep-sales.com/medicaloffice or contact Emilio Amendola, (631) 465-9507, emilio@agrep.com; Jamie Cote, (312) 203-6321, jcote@agrep.com; Katie Decoste, (773) 615-1292, kdecoste@agrep.com; or Christian Koulichkov, (617) 335-3940, ckoulichkov@agrep.com.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”